POLITICS & INSTITUTIONS - POLITICS

Sars-CoV-2 monitoring

General population serology tests to cease by the end of 2021



Library photo shows a COVID-19  serological diagnostic testing procedure  Shutterstock

Library photo shows a COVID-19  serological diagnostic testing procedure  Shutterstock

The public will continue to be invited at random for serology tests to monitor the development of Sars-CoV-2 antibodies until the end of 2021, the health ministry has confirmed.

Responding to a parliamentary question, Paulette Lenert (LSAP) said that in addition to the representative sample tests, all residents and staff at nursing homes have been tested for antibodies.

“Through this initiative it is possible to have a better overview of the general presence of covid antibodies among staff and residents of retirement and care homes and on the basis of from these data, to decide on new or adapted measures in the houses,” the minister wrote.

These tests in care homes are scheduled every four to five months and are expected to continue until 2023, the minister said, adding that cellular immunity also plays an important role. No third vaccinations are offered to the general population in Luxembourg, Lenert wrote, however, the infectious diseases advisory board has recommended that these be offered to vulnerable residents.